Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer-related Venous Thromboembolism”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableStudy completedNCT01444612
What this trial is testing

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 4,068
Not applicableLooking for participantsNCT07372716
What this trial is testing

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

Who this might be right for
ThrombosisCancerThrombosis, Deep Vein+3 more
Ottawa Hospital Research Institute 700
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Post-approval studies (Phase 4)Looking for participantsNCT06603870
What this trial is testing

Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis

Who this might be right for
Venous ThromboembolismCancerUpper Extremity Deep Vein Thrombosis+1 more
Ottawa Hospital Research Institute 330
Not applicableLooking for participantsNCT03407469
What this trial is testing

Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

Who this might be right for
Cancer-related Venous Thromboembolism
M.D. Anderson Cancer Center 260
Not applicableLooking for participantsNCT06393764
What this trial is testing

Cancer-related Venous Thromboembolic Disease - Cohort Study

Who this might be right for
Thrombosis EmbolismThromboses, VenousCancer
University Hospital, Brest 150
Not applicableUnknownNCT02785757
What this trial is testing

Cancer-related Thromboembolic Disease

Who this might be right for
Adenocarcinoma
Hospices Civils de Lyon 18
Large-scale testing (Phase 3)Study completedNCT02585713
What this trial is testing

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisGonadal Thrombosis+9 more
Academic and Community Cancer Research United 300
Large-scale testing (Phase 3)Study completedNCT03080883
What this trial is testing

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+4 more
Academic and Community Cancer Research United 370
Large-scale testing (Phase 3)UnknownNCT01589146
What this trial is testing

ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.

Who this might be right for
The Primary Study Objective is to Assess the Efficacy andSafety of Extended 4-week Heparin Prophylaxis Compared toProphylaxis Given for 8±2 Days After Planned Laparoscopic+4 more
University Of Perugia 400